Skip to main content
Have a personal or library account? Click to login
Radiotherapy for malignant spinal cord compression - prognostic factors for better functional outcome Cover

Radiotherapy for malignant spinal cord compression - prognostic factors for better functional outcome

Open Access
|Mar 2026

References

  1. Lawton AJ, Lee KA, Cheville AL, Ferrone ML, Rades D, Balboni TA, et al. Assessment and management of patients with metastatic spinal cord compression: a multidisciplinary review. J Clin Oncol 2019; 37: 61-71. doi: 10.1200/JCO.2018.78.1211
  2. Prasad D, Schiff D. Malignant spinal-cord compression. Lancet Oncol 2005; 6: 15-24. doi: 10.1016/S1470-2045(04)01709-7
  3. Boussios S, Cooke D, Hayward C, Kanellos FS, Tsiouris AK, Chatziantoniou AA, et al. Metastatic spinal cord compression: unraveling the diagnostic and therapeutic challenges. Anticancer Res 2018; 38: 4987-97. doi: 10.21873/anticanres.12817
  4. Liu YH, Hu YC, Yang XG, Lun DX, Wang F, Yang L, et al. Prognostic factors of ambulatory status for patients with metastatic spinal cord compression: a systematic review and meta-analysis. World Neurosurg 2018; 116: e278-90. doi: 10.1016/j.wneu.2018.04.188
  5. Gould Rothberg BE, Quest TE, Yeung SJ, Pelosof LC, Gerber DE, Seltzer JA, et al. Oncologic emergencies and urgencies: a comprehensive review. CA Cancer J Clin 2022; 72: 570-93. doi: 10.3322/caac.21727
  6. Higdon ML, Atkinson CJ, Kelley V. Lawrence oncologic emergencies: recognition and initial management. Am Fam Physician 2018; 94: 741-8. PMID: 30215936
  7. Kienstra GEM, Terwee CB, Dekker FW, Canta LR, Borstlap ACW, Tijssen CC, et al. Prediction of spinal epidural metastases. Arch Neurol 2000; 57: 690-5. doi: 10.1001/archneur.57.5.690
  8. Rades D, Cacicedo J, Conde-Moreno AJ, Segedin B, But-Hadzic J, Groselj B, et al. Precision radiation therapy for metastatic spinal cord compression: final results of the PRE-MODE Trial. Int J Radiat Oncol Biol Phys 2020; 106: 780-9. doi: 10.1016/j.ijrobp.2019.11.401
  9. Rades D, Šegedin B, Conde-Moreno AJ, Garcia R, Perpar A, Metz M, et al. Radiotherapy with 4 Gy × 5 versus 3 Gy × 10 for metastatic epidural spinal cord compression: final results of the SCORE-2 Trial (ARO 2009/01). J Clin Oncol 2016; 34: 597-602. doi: 10.1200/JCO.2015.64.0862
  10. Rades D, Lomidze D, Jankarashvili N, Lopez Campos F, Navarro-Martin A, Segedin B, et al. Radiotherapy for metastatic epidural spinal cord compression with increased doses: final results of the RAMSES-01 Trial. Cancers (Basel) 2024; 16: 1-12. doi: 10.3390/cancers16061149
  11. Giraldo A, Benavente S, Ramos M, Vergés R, Coronil O, Arbeláez L, et al. Effectiveness of radiotherapy for metastatic spinal cord compression in patients with short life expectancy. Reports Pract Oncol Radiother 2017; 22: 58-63. doi: 10.1016/j.rpor.2016.09.007
  12. Qamar FU, Sajjad K, Haide I, Khan FU, Inam Y, Anjum M. Role of palliative radiotherapy in improving performance status and quality of life in patients with metastatic spinal cord compression. J Ayub Med Coll Abbottabad 2022; 34: 949-52. doi: 10.55519/JAMC-04-S4-10570
  13. Oldenburger E, Brown S, Willmann J, van der Velden JM, Spałek M, van der Linden YM, et al. ESTRO ACROP Guidelines for External Beam Radiotherapy of Patients with Complicated Bone Metastases. Radiother Oncol 2022; 173: 240-53. doi: 10.1016/j.radonc.2022.06.002
  14. Hoskin PJ, Hopkins K, Misra V, Holt T, McMenemin R, McKinna F, et al. Prognostic factors for survival and ambulatory status at 8 weeks with metastatic spinal cord compression in the SCORAD Randomised Trial. Radiother Oncol 2022; 173: 77-83. doi: 10.1016/j.radonc.2022.05.017.
  15. Rades D, Schild SE. Personalization of radiation therapy in the primary treatment of malignant epidural spinal cord compression (MESCC). Semin Radiat Oncol 2023; 33: 148-58. doi: 10.1016/j.semradonc.2022.11.005.
  16. Maranzano E, Trippa F, Casale M, Costantini S, Lupattelli M, Bellavita R, et al. 8 Gy single-dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiother Oncol 2009; 93: 174-9. doi: 10.1016/j.radonc.2009.05.012
  17. Abu-Hegazy M, Wahba H. Single-versus multi-fraction radiation treatment for metastatic spinal cord compression: Functional Outcome Study (S45.005). [abstract]. Neurology 2012; 78(1 Suppl): S45.005. doi: 10.1212/wnl.78.1_meetingabstracts.s45.005
  18. Donovan EK, Sienna J, Mitera G, Kumar-Tyagi N, Parpia S, Swaminath A. Single versus multifraction radiotherapy for spinal cord compression: a systematic review and meta-analysis. Radiother Oncol 2019; 134: 55-66. doi: 10.1016/j.radonc.2019.01.019
  19. Lee KA, Dunne M, Small C, Kelly PJ, McArdle O, O’Sullivan J, et al. (ICORG 05-03): Prospective randomized non-inferiority phase III Trial comparing two radiation schedules in malignant spinal cord compression (not proceeding with surgical decompression); the quality of life analysis. Acta Oncol (Madr) 2018; 57: 965-72. doi: 10.1080/0284186X.2018.1433320
  20. Hoskin PJ, Reczko K, Rashid M, Hackshaw A, Lopes A, Hopkins K, et al. Quality-of-life outcomes in metastatic spinal cord compression: findings from the SCORAD Trial. J Natl Cancer Inst 2024; 116: 1087-94. doi:10.1093/jnci/djae039
  21. Rades D, Šegedin B, Conde-Moreno AJ, Ferrer-Albiach C, Metz M, Polat B, et al. Patient-reported outcomes - secondary analysis of the SCORE-2 Trial comparing 4 Gy × 5 to 3 Gy × 10 for metastatic epidural spinal cord compression. Int J Radiat Oncol Biol Phys 2019; 105: 760-4. doi: 10.1016/J.ijrobp.2019.08.002
  22. Rades D, Stalpers LJA, Veninga T, Schulte R, Hoskin PJ, Obralic N, et al. Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. J Clin Oncol 2005; 23: 3366-75. doi:10.1200/JCO.2005.04.754
  23. Rades D, Conde-Moreno AJ, Cacicedo J, Veninga T, Segedin B, Stanic K, et al. 1 x 8 Gy versus 5 x 4 Gy for metastatic epidural spinal cord compression: a matched-pair study of three prognostic patient subgroups. Radiat Oncol 2018; 13: 21. doi: 10.1186/s13014-018-0968-3
  24. NICE. National Institute for Health and Care excellence. Spinal metastases and metastatic spinal cord compression. NICE Guideline NG234 2023; 1-79. [internet]. Available at: https://www.nice.org.uk/guidance/ng234
  25. Rades D, Al-Salool A, Staackmann C, Cremers F, Cacicedo J, Lomidze D, et al. A New clinical instrument for estimating the ambulatory status after irradiation for malignant spinal cord compression. Cancers (Basel) 2022; 14: 1-12. doi: 10.3390/cancers14153827
  26. Rades D, Cacicedo J, Lomidze D, Al-Salool A, Segedin B, Groselj B, et al. A new and easy-to-use survival score for patients irradiated for metastatic epidural spinal cord compression. Pract Radiat Oncol 2022; 12: 354-62. doi: 10.1016/j.prro.2022.03.012
  27. Yano N, Ono T, Yamada M, Kawashiro S, Harada M, Akamatsu H, et al. MRI grading scale predicts ambulatory function after radiotherapy for metastatic spinal cord compression. A prospective single-institution observational study. Oncol Ther 2022; 10: 493-501. doi: 10.1007/s40487-022-00204-5
  28. Bilsky MH, Laufer I, Fourney DR, Groff M, Schmidt MH, Varga PP, et al. Reliability analysis of the Epidural Spinal Cord Compression Scale. J Neurosurg Spine 2010; 13: 324-8. doi: 10.3171/2010.3.SPINE09459
  29. Hoskin PJ, Hopkins K, Misra V, Holt T, Mcmenemin R, Dubois D, et al. Effect of single-fraction vs multifraction radiotherapy on ambulatory status among patients with spinal canal compression from metastatic cancer: The SCORAD Randomized Clinical Trial. JAMA - J Am Med Assoc 2019; 322: 2084-94. doi: 10.1001/jama.2019.17913
  30. Rades D, Rudat V, Veninga T, Stalpers LJA, Basic H, Karstens JH, et al. A score predicting posttreatment ambulatory status in patients irradiated for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys 2008; 72: 905-8. doi: 10.1016/j.ijrobp.2008.02.018
  31. Dearnaley D, Hinder V, Hijab A, Horan G, Srihari N, Rich P, et al. Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trial. Lancet Oncol 2022; 23: 501-13. doi: 10.1016/S1470-2045(22)00092-4
  32. Rades D, Segedin B, Schild SE, Lomidze D, Veninga T, Cacicedo J. Identifying patients with malignant spinal cord compression (MSCC) near end of life who can benefit from palliative radiotherapy. Radiat Oncol 2022; 17: 1-8. doi: 10.1186/s13014-022-02117-z
  33. da Silva GT, Bergmann A, Thuler LCS. Prognostic factors in patients with metastatic spinal cord compression secondary to lung cancer: a systematic review of the literature. Eur Spine J 2015; 24: 2107-13. doi: 10.1007/s00586-015-4157-x
  34. Mui WH, Lam TC, Wong FCS, Sze WK. Survival analysis of malignant epidural spinal cord compression after palliative radiotherapy using Tokuhashi Scoring System and the impact of systemic therapy. Ann Palliat Med 2017; 6(Suppl 2): S132-9. doi: 10.21037/apm.2017.07.06
DOI: https://doi.org/10.2478/raon-2026-0013 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 132 - 140
Submitted on: Feb 12, 2026
Accepted on: Feb 19, 2026
Published on: Mar 24, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Jasna But-Hadzic, Blaz Groselj, Dirk Rades, Barbara Segedin, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.